They detected MMR deficiency in 1.2% (6/508) of unselected colorectal adenomas, and germline MMR gene testing of these patients resulted in an LS diagnosis in 0.6% (3/508, 95% CI: 0.1–1.7%) of the cohort. This evidence concerns the gene MRC1 and mismatch repair cancer syndrome 1.